Advanced Medical Optics to Change NYSE Ticker Symbol to 'EYE' Effective June 8 SANTA ANA, Calif., June 6 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) (NYSE:AVO), announced today that, effective June 8, shares of its common stock will begin trading on the New York Stock Exchange (NYSE) under the ticker symbol "EYE." (Logo http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO ) AMO also announced that on June 8, AMO President and CEO Jim Mazzo and AMO Chairman of the Board William Grant, will ring the opening bell at the NYSE to commemorate the ticker symbol change and the company's recent acquisition of VISX, Incorporated on May 27. "The EYE symbol captures perfectly AMO's focus on delivering innovative vision technologies that optimize the quality of life for people of all ages," said Mazzo. "With the acquisition of VISX, we are now a company with annual revenues in excess of $1 billion and a portfolio of refractive products second to none. This global refractive leadership complements our already strong position in the global cataract and eye care markets." About Advanced Medical Optics (AMO) AMO is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO owns or has the rights to such ophthalmic surgical product brands as ReZoom(TM), Phacoflex(R), Clariflex(R), Array(R), Sensar(R), CeeOn(R), Tecnis(R) and Verisyse(TM) intraocular lenses, STAR S4(TM) laser vision correction system, WaveScan Wavefront(R) System, CustomVue(TM) procedure, Sovereign(R) and Sovereign(R) Compact(TM) phacoemulsification systems with WhiteStar(TM) technology, Amadeus(TM) and Amadeus(TM) II microkeratomes, Healon(R) and Vitrax(R) viscoelastics, and the Baerveldt(R) glaucoma shunt. Products in the contact lens care line include disinfecting solutions, daily cleaners, enzymatic cleaners and lens rewetting drops. Among the contact lens care product brands the company possesses are COMPLETE(R) Moisture PLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(R) and blink(TM)branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and employs approximately 3,500 worldwide. The company has operations in about 20 countries and markets products in approximately 60 countries. For more information, visit the company's Web site at http://www.amo-inc.com/. Cautionary Statement Regarding Forward-Looking Statements Statements contained in this document that refer to the expected change in ticker symbol are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and beliefs and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Therefore, actual outcomes and results may differ materially from what is expressed herein. Other risk factors are set forth in AMO's most recent Annual Report on Form 10-K. AMO is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events, or otherwise. Advanced Medical Optics, Inc. Investors: Sheree Aronson (714) 247-8290 Media: Steve Chesterman (714) 247-8711 http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO http://photoarchive.ap.org/ DATASOURCE: Advanced Medical Optics, Inc. CONTACT: investors, Sheree Aronson, +1-714-247-8290, or , or media, Steve Chesterman, +1-714-247-8711, or , both of Advanced Medical Optics, Inc. Web site: http://www.amo-inc.com/

Copyright